Vaccine News and Research

Latest Vaccine News and Research

Study: PROSTVAC-VF vaccine effective in treating patients with metastatic prostate cancer

In a newly published clinical trial, patients with metastatic prostate cancer who received a vaccine of harmless poxviruses engineered to spur an immune system attack on prostate tumor cells lived substantially longer than patients who received a placebo vaccine, report researchers at Dana-Farber Cancer Institute and affiliated organizations.

27 Jan 2010

Gates annual letter addresses importance of innovation for global health, agriculture

In his second annual letter, Bill Gates reflects on the Bill & Melinda Gates Foundation's work and the importance innovation will play in overcoming some of the world's greatest challenges, including in global health and agriculture, the Associated Press reports. "Gates says the foundation currently is backing 30 areas of innovation including online learning, teacher improvement, malaria vaccine development, HIV prevention, and genetically modified seeds," according to the news service (Gordon Blankinship, 1/25).

27 Jan 2010

UCF researcher develops first dual vaccine to fight malaria and cholera

A University of Central Florida biomedical researcher has developed what promises to be the first low-cost dual vaccine against malaria and cholera.

27 Jan 2010

Dr. Shinya Yamanaka to receive the 2010 March of Dimes Prize in Developmental Biology

The scientist who reprogrammed adult cells into embryonic-like stem cells has been chosen to receive the 2010 March of Dimes Prize in Developmental Biology.

27 Jan 2010

Health care providers play a critical role in H1N1 vaccinations

Results from the latest C.S. Mott Children's Hospital National Poll on Children's Health indicate health care providers play a critical role in influencing parents and patients to vaccinate their children and themselves against H1N1 flu.

27 Jan 2010

WHO rejects accusations it mishandled H1N1, updates worldwide stats

WHO spokesperson Gregory Hartl on Monday rejected accusations that the organization miscategorized H1N1 (swine flu) as a pandemic, calling such accusations "irresponsible," the Associated Press/Washington Post reports. "WHO also dismissed claims it colluded with drug companies to bring economic benefit to the industry by playing up the danger of the new H1N1 [swine flu] influenza strain," the news service writes.

27 Jan 2010

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Texas plans to invest $3 billion in cancer research over the next 10 years and six scientists at The University of Texas Health Science Center at Houston are among the first to receive grants.The researchers, whose grants total $4.5 million, are working to protect girls from cervical cancer, to interrupt tumor growth at the molecular level and to develop a new approach for the treatment of colon cancer, among other cutting-edge projects.

27 Jan 2010

Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection

Dynavax Technologies Corporation announced today data from two studies that differentiate SD-101 from standard-of-care as well as emerging treatments for chronic HCV infection. The findings of a Phase 1b clinical trial and an in vitro study of SD-101's mechanism of action show that the second-generation TLR9 agonist is well tolerated and safe and induces both IFN-lambda and IFN-alpha at concentrations producing antiviral activity. The data will be presented at the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria in April 2010.

27 Jan 2010

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

The Institute of Medicine, a branch of the US National Academy of Sciences, is urging healthcare providers to take steps to battle liver-damaging hepatitis B and C, which are often overlooked viruses.

25 Jan 2010

Research paves way for future vaccine against gastric adenocarcinoma

Despite a strong response from our immune defence, the body is unable to rid itself of the bacterium Helicobacter pylori. One reason for this is that this bacterium encourages elements of the immune response to remain in tissue, activating the wrong immune cells. Research results that pave the way for a future vaccine are now being published by the Sahlgrenska Academy at the University of Gothenburg, Sweden.

25 Jan 2010

Bill Gates' annual letter highlights innovations aimed at combating disease, hunger and poverty

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, today released his second annual letter -- a personal appraisal of the foundation's efforts to date and how innovation impacts priorities of the foundation.

25 Jan 2010

Erbitux improves survival of mCRC patients with KRAS wild-type tumors

Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that Erbitux® (cetuximab) provided an improvement in overall survival (OS) when added to the standard 1st-line FOLFIRI chemotherapy regimen for metastatic colorectal cancer (mCRC) patients with KRAS wild-type tumors in the CRYSTAL study.

24 Jan 2010

Vaccination for children: Pros and cons

ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"

23 Jan 2010

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

In an effort to ensure that Pennsylvania's citizens are protected against the H1N1 flu virus, the Department of Health will continue public vaccination clinics at all 60 state health centers every Saturday through Feb. 6 from 9 a.m. to noon.

23 Jan 2010

USPTO issues new patent for Advaxis' intellectual property portfolio

The U.S. Patent and Trademark Office (USPTO) issued today patent 7,635,479, "Compositions and Methods for Enhancing the Immunogenicity of Antigens,” by Dr. Yvonne Paterson, et al, which is assigned to the Trustees of the University of Pennsylvania and licensed to Advaxis, Incorporated (OTCBB: ADXS).

22 Jan 2010

GSK announces new initiatives for addressing healthcare challenges in the world's poorest countries

Andrew Witty, Chief Executive of GlaxoSmithKline, today announced a series of new initiatives targeted at further transforming the company's approach to diseases that disproportionately affect the world's poorest countries. His announcements build on commitments made in 2009 to work in partnership, expand access to medicines and encourage new research into neglected tropical diseases.

22 Jan 2010

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

New video footage of a virus infecting cells is challenging what researchers have long believed about how viruses spread, suggesting that scientists may be able to create new drugs to tackle some viruses.

22 Jan 2010

Controversy around Merck's pricing for its AIDS drug Isentress

The controversy around Merck and Co. Pharmaceuticals’ pricing for its key AIDS drug Isentress — at nearly $13,000 per patient yearly, the most expensive first line AIDS therapy on the US market today — continued this week following Merck’s reaction to recent public criticism of its AIDS drug pricing. Merck ramped up its damage control PR efforts, issuing a press release that sought to rewrite the history of Isentress and deflect attention by claiming AIDS Healthcare Foundation has been unfairly attacking them.

22 Jan 2010

Findings may provide new insights into diabetes; suggest novel targets for drug intervention

The neuropeptide corticotropin-releasing factor (CRF) makes cameo appearances throughout the body, but its leading role is as the opening act in the stress response, jump-starting the process along the hypothalamus-pituitary-adrenal (HPA) axis. Researchers at the Salk Institute for Biological Studies have found that CRF also plays a part in the pancreas, where it increases insulin secretion and promotes the division of the insulin-producing beta cells.

22 Jan 2010

Clorox urges organizations to equip with flu prevention educational tools to prevent virus spread

Seasonal flu activity typically peaks in January or later, according to the Centers for Disease Control and Prevention (CDC), and the flu virus can spread as late as May. On top of the rising seasonal flu activity, this season the 2009 H1N1 virus is also circulating. Organizations – and particularly mass transportation systems where many people pass through daily – need to be ready to combat and help prevent the further spread of both flu viruses this winter and spring.

22 Jan 2010

Vaccine News and Research

Latest Vaccine News and Research

Study: PROSTVAC-VF vaccine effective in treating patients with metastatic prostate cancer

Gates annual letter addresses importance of innovation for global health, agriculture

UCF researcher develops first dual vaccine to fight malaria and cholera

Dr. Shinya Yamanaka to receive the 2010 March of Dimes Prize in Developmental Biology

Health care providers play a critical role in H1N1 vaccinations

WHO rejects accusations it mishandled H1N1, updates worldwide stats

Texas to invest $4.5 mn in cancer research at UT Health Science Center

Dynavax Technologies to present data on its SD-101 Phase 1b trial for chronic HCV infection

Institute of Medicine urges healthcare providers to take steps to battle hepatitis B and C

Research paves way for future vaccine against gastric adenocarcinoma

Bill Gates' annual letter highlights innovations aimed at combating disease, hunger and poverty

Erbitux improves survival of mCRC patients with KRAS wild-type tumors

Vaccination for children: Pros and cons

Department of Health to continue H1N1 vaccination clinics every Saturday in Pennsylvania

USPTO issues new patent for Advaxis' intellectual property portfolio

GSK announces new initiatives for addressing healthcare challenges in the world's poorest countries

New study indicates viruses employ a novel mechanism to spread more quickly than thought possible

Controversy around Merck's pricing for its AIDS drug Isentress

Findings may provide new insights into diabetes; suggest novel targets for drug intervention

Clorox urges organizations to equip with flu prevention educational tools to prevent virus spread

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Vaccine News and Research

Latest Vaccine News and Research

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Newsletters you may be interested in